Abstracts

Electroclinical features in PCDH19 developmental and epileptic encephalopathy

Abstract number : 3.261
Submission category : 4. Clinical Epilepsy / 4A. Classification and Syndromes
Year : 2025
Submission ID : 563
Source : www.aesnet.org
Presentation date : 12/8/2025 12:00:00 AM
Published date :

Authors :
Presenting Author: Shu Ning Liu, MD – Taichung Veterans General Hospital

Hsiu Fen Lee, PhD – Taichung Veterans General Hospital
Ching Shiang Chi, PhD – Taichung Veterans General Hospital
Chi Ren Tsai, PhD – Taichung Veterans General Hospital
Chin Hsuan chen, Neurodiagnostic Technologist – Taichung Veterans General Hospital
Li Wen Wang, Neurodiagnostic Technologist – Taichung Veterans General Hospital
Yao Lun Yang, MD – Taichung Veterans General Hospital
Pei Yu Wu, MD – Taichung Veterans General Hospital

Rationale: PCDH19 developmental and epileptic encephalopathy (DEE) is a childhood-onset epilepsy syndrome that occurs exclusively in females. The aim of this study was to describe electroclinical features of PCDH19 DEE.

Methods: This was a retrospective cohort study conducted in a single medical center from March 2021 to May 2025. Individuals who were diagnosed with PCDH19 DEE were recruited. The demographic data, clinical manifestations, electroencephalography (EEG), neuroimaging findings, causative gene variants, and neurodevelopmental outcomes of the eligible individuals were analyzed.

Results:

Four individuals who had epileptic seizures and carried PCDH19 pathogenic variants were enrolled. The age at seizure onset ranged from 8 months to 20 months of age following an upper respiratory tract infection or a fever after immunization. All individuals had cluster seizures during an illness.
Individual 1 primarily presented with myoclonic seizures and automatism, and her interictal EEG showed generalized background slowing and focal spikes. Individual 2 initially showed febrile and afebrile seizures, subsequently developed cluster attacks with pleomorphic seizure types, followed by acute encephalopathy after an episode of SARS-CoV-2 virus infection; and ictal EEG revealed multifocal spikes, ictal shifts, and a burst suppression pattern, mimicking the ictal EEG feature of febrile-infection related epileptic syndrome (FIRES). Individual 3 had focal tonic seizures with impaired awareness or automatism, while interictal EEG showed a normal result. Individual 4 exhibited generalized tonic, tonic-clonic seizures, or automatism, and the interictal EEG demonstrated generalized background slowing and focal spikes. Brain magnetic resonance imaging features were unremarkable in individuals 1, 3, and 4, while individual 2 had T2-weighted hyperintensity in the bilateral parietal-temporal regions. The identified PCDH19 causative variants were p.Phe206Cys in individual 1, p.Ile178GlnfsTer47 in individual 2, and p.Pro561Arg in individuals 3 and 4, who are siblings.
During a follow-up period ranged from 1 year and 2 months to 4 years and 2 months, the clinical outcomes varied: individual 1 had profound psychomotor impairment, individual 2 was mild developmental delay, and individuals 3 and 4 achieved normal developmental milestones.



Conclusions: PCDH19 DEE is characterized by recurrent clusters of seizures triggered by elevated body temperature along with cognitive impairment and behavioral disturbances resembling those epilepsies or epileptic syndromes with fever sensitivity. Recognition of its electroclinical features could proceed genetic testing earlier to provide genetic counseling.

Funding: nil

Clinical Epilepsy